JPWO2023076626A5 - - Google Patents
Info
- Publication number
- JPWO2023076626A5 JPWO2023076626A5 JP2024525599A JP2024525599A JPWO2023076626A5 JP WO2023076626 A5 JPWO2023076626 A5 JP WO2023076626A5 JP 2024525599 A JP2024525599 A JP 2024525599A JP 2024525599 A JP2024525599 A JP 2024525599A JP WO2023076626 A5 JPWO2023076626 A5 JP WO2023076626A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- halo
- substituents
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273228P | 2021-10-29 | 2021-10-29 | |
| US63/273,228 | 2021-10-29 | ||
| PCT/US2022/048277 WO2023076626A1 (en) | 2021-10-29 | 2022-10-28 | Rxfp1 agonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540164A JP2024540164A (ja) | 2024-10-31 |
| JPWO2023076626A5 true JPWO2023076626A5 (https=) | 2025-10-30 |
| JP2024540164A5 JP2024540164A5 (https=) | 2025-10-30 |
Family
ID=84688378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525599A Pending JP2024540164A (ja) | 2021-10-29 | 2022-10-28 | Ｒｘｆｐ１アゴニスト |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20250221966A1 (https=) |
| EP (1) | EP4422746A1 (https=) |
| JP (1) | JP2024540164A (https=) |
| KR (1) | KR20240099354A (https=) |
| CN (1) | CN118843613A (https=) |
| AR (1) | AR127507A1 (https=) |
| AU (1) | AU2022378644A1 (https=) |
| CA (1) | CA3234990A1 (https=) |
| CL (1) | CL2024001268A1 (https=) |
| CO (1) | CO2024005247A2 (https=) |
| IL (1) | IL312125A (https=) |
| MX (1) | MX2024005142A (https=) |
| PE (1) | PE20241188A1 (https=) |
| TW (1) | TW202333663A (https=) |
| WO (1) | WO2023076626A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121605099A (zh) * | 2023-08-10 | 2026-03-03 | 深圳信立泰药业股份有限公司 | 一种rxfp1受体调节剂及其制备方法和医药用途 |
| TW202530177A (zh) * | 2023-10-13 | 2025-08-01 | 大陸商江蘇恆瑞醫藥股份有限公司 | 醯胺取代的環烷基類化合物、其製備方法及其在醫藥上的應用 |
| JP7788532B2 (ja) | 2023-12-15 | 2025-12-18 | イーライ リリー アンド カンパニー | Ｒｘｆｐ１受容体アゴニスト |
| WO2026041118A1 (zh) * | 2024-08-22 | 2026-02-26 | 江苏恒瑞医药股份有限公司 | 酰胺取代的环烷基类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013165606A1 (en) * | 2012-05-04 | 2013-11-07 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Modulators of the relaxin receptor 1 |
| AR124193A1 (es) * | 2020-12-08 | 2023-02-22 | Astrazeneca Ab | Compuestos moduladores de rxfp1 |
-
2022
- 2022-10-28 AR ARP220102954A patent/AR127507A1/es not_active Application Discontinuation
- 2022-10-28 PE PE2024000923A patent/PE20241188A1/es unknown
- 2022-10-28 US US18/700,349 patent/US20250221966A1/en active Pending
- 2022-10-28 AU AU2022378644A patent/AU2022378644A1/en active Pending
- 2022-10-28 MX MX2024005142A patent/MX2024005142A/es unknown
- 2022-10-28 IL IL312125A patent/IL312125A/en unknown
- 2022-10-28 KR KR1020247017527A patent/KR20240099354A/ko active Pending
- 2022-10-28 CN CN202280073221.4A patent/CN118843613A/zh active Pending
- 2022-10-28 EP EP22830974.6A patent/EP4422746A1/en active Pending
- 2022-10-28 WO PCT/US2022/048277 patent/WO2023076626A1/en not_active Ceased
- 2022-10-28 JP JP2024525599A patent/JP2024540164A/ja active Pending
- 2022-10-28 CA CA3234990A patent/CA3234990A1/en active Pending
- 2022-10-28 TW TW111141101A patent/TW202333663A/zh unknown
-
2024
- 2024-04-24 CO CONC2024/0005247A patent/CO2024005247A2/es unknown
- 2024-04-24 CL CL2024001268A patent/CL2024001268A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021088610A5 (https=) | ||
| JP2021534106A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| JP2021535174A5 (https=) | ||
| RU2006112428A (ru) | Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение | |
| JP2008510691A5 (https=) | ||
| JP2020526484A5 (https=) | ||
| JPWO2023060253A5 (https=) | ||
| CA2474874A1 (en) | Anticholinergic agents, method for producing the same and use thereof as medicaments | |
| JPWO2023076626A5 (https=) | ||
| JP2006508090A5 (https=) | ||
| JPWO2020051105A5 (https=) | ||
| RU2002118700A (ru) | Замещенные производные норборниламина, способ их получения, их применение в качестве медикаментов или диагностических средств, а также содержащие их медикаменты | |
| JPWO2020051139A5 (https=) | ||
| SK281025B6 (sk) | (1-fenyl-1-heterocyklyl)alkánové deriváty, spôsoby ich prípravy, medziprodukty na ich prípravu, farmaceutické prostriedky s ich obsahom a ich použitie | |
| RU2159227C2 (ru) | Нитробензамиды, фармацевтическая композиция, способ ее получения и способ лечения и/или профилактики аритмий и ишемических нарушений ритма | |
| JPWO2022198196A5 (https=) | ||
| KR101763740B1 (ko) | 탄소환 뉴클레오시드 및 이들의 약학적 용도 및 조성물 | |
| JPWO2023077040A5 (https=) | ||
| JPWO2023077070A5 (https=) | ||
| JPWO2023114823A5 (https=) | ||
| JPWO2023077041A5 (https=) | ||
| JPWO2020219417A5 (https=) | ||
| JP2005529110A5 (https=) | ||
| JPWO2020010309A5 (https=) |